Abstract
MicroRNAs (miRNAs) are an emerging class of highly conserved, non-coding small RNAs that regulate gene expression on the post-transcriptional level by inhibiting the translation of protein from mRNA or by promoting the degradation of mRNA. The involvement of miRNAs in the regulation of lipid metabolism, inflammatory response, cell cycle progression and proliferation, oxidative stress, platelet activation, endothelial function, angiogenesis and plaque formation and rapture indicates important roles in the initiation and progression of atherosclerosis. In the light of this evidence we will review the role of miRNAs in atherosclerosis.
Keywords: microRNAs, atherosclerosis, inflammation, endothelial function.
Current Topics in Medicinal Chemistry
Title:MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
Volume: 13 Issue: 13
Author(s): Gerasimos Siasos, Christina Kollia, Vasiliki Tsigkou, Efthimia K. Basdra, Maria Lymperi, Evangelos Oikonomou, Eleni Kokkou, Porfyrios Korompelis and Athanasios G. Papavassiliou
Affiliation:
Keywords: microRNAs, atherosclerosis, inflammation, endothelial function.
Abstract: MicroRNAs (miRNAs) are an emerging class of highly conserved, non-coding small RNAs that regulate gene expression on the post-transcriptional level by inhibiting the translation of protein from mRNA or by promoting the degradation of mRNA. The involvement of miRNAs in the regulation of lipid metabolism, inflammatory response, cell cycle progression and proliferation, oxidative stress, platelet activation, endothelial function, angiogenesis and plaque formation and rapture indicates important roles in the initiation and progression of atherosclerosis. In the light of this evidence we will review the role of miRNAs in atherosclerosis.
Export Options
About this article
Cite this article as:
Siasos Gerasimos, Kollia Christina, Tsigkou Vasiliki, Basdra K. Efthimia, Lymperi Maria, Oikonomou Evangelos, Kokkou Eleni, Korompelis Porfyrios and Papavassiliou G. Athanasios, MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis, Current Topics in Medicinal Chemistry 2013; 13 (13) . https://dx.doi.org/10.2174/15680266113139990099
DOI https://dx.doi.org/10.2174/15680266113139990099 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial: Atrial Fibrillation after Coronary Surgery: The Need for an Effective Pharmacological Prophylaxis
Current Vascular Pharmacology Differential Effects of Trans and Polyunsaturated Fatty Acids on Ischemia/ Reperfusion Injury and its Associated Cardiovascular Disease States
Current Pharmaceutical Design Powerful Technique to Test Selectivity of Agents Acting on Cardiac Ion Channels: The Action Potential Voltage-Clamp
Current Medicinal Chemistry Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Current Pharmaceutical Design A Tour of Unsupervised Deep Learning for Medical Image Analysis
Current Medical Imaging Blood Pressure Variability and Mortality in end Stage Renal Disease
Current Hypertension Reviews Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Editorial (Novel Therapies and Botanical and Mechanical Approaches for Management of Cardiovascular Disease)
Recent Patents on Cardiovascular Drug Discovery Molecular Aspects of Modulation of L-type Calcium Channels by Protein Kinase C
Current Molecular Pharmacology The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Current Pharmaceutical Design Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Post-stroke Depression Therapy: Where are we now?
Current Neurovascular Research Multi-Modality Cardiac Imaging in Interventional Cardiology
Current Medical Imaging Clinical Applications for Cardiovascular Magnetic Resonance Imaging at 3 Tesla
Current Cardiology Reviews